• 

  How Problematic Protein TDP-43 Wreaks Havoc In the Brain
• 

  Little-Known Cuban Alzheimer’s Drug Goes to Human Trials in Canada
• 

  FDA Approves the First Drug for Alzheimer’s Agitation: Rexulti
• 

  What Does Omega-3 Fish Oil Do for Dementia Risk?
• 

  The U.S. Is Building a Massive Database of Public Health Data
• 

  Here’s What You Need to Know About Cannabis and Cognitive Decline
• 

  Sneak Peek of Trial Data for Alzheimer’s Drug Donanemab
• 

  Marauders of the Microbiome: Certain Gut Bacteria Found Thriving in People With Alzheimer’s, APOE4
• 

  Why Is This New Generation of Alzheimer’s Drugs Such a Big Deal?
• 

  On the Verge of Full FDA Approval, New Details About Leqembi Death
• 

  Filling the Void: The Race to Treat Later-Stage Alzheimer’s
• 

  Respiratory Infections Like Flu Appear to Triple Alzheimer’s Risk
• 

  In Alzheimer’s, Hallucinations Signal Faster Cognitive Decline
• 

  Please Don’t Stop the Music: 3 Ways to Use Music As Therapy Dementia Care
• 

  Does Neuriva Plus Work? A Settled Lawsuit Bars Its Makers From Claiming It Does

Previous192021Next